Chemical Agents That Inhibit Platelet Aggregation
- 1 January 1992
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Anagrelide: A New Drug for Treating ThrombocytosisNew England Journal of Medicine, 1988
- Isolation and characterization of a platelet surface collagen binding complex related to VLA-2Biochemical and Biophysical Research Communications, 1988
- Evidence for the release of arachidonic acid through the selective action of phospholipase A2 in thrombin-stimulated human plateletsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Vasopressin inhibits the adenylate cyclase activity of human platelet particulate fraction through V1‐receptorsFEBS Letters, 1983
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Synergistic functions of phorbol ester and calcium in serotonin release from human plateletsBiochemical and Biophysical Research Communications, 1983
- Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonistInflammation Research, 1982
- Sulfinpyrazone after Myocardial InfarctionNew England Journal of Medicine, 1978
- Clofibrate Reversal of Platelet Hypersensitivity in HyperbetalipoproteinemiaCirculation, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970